search
Back to results

Erector Spinae Block vs. Placebo Block Study

Primary Purpose

Breast Cancer, Nerve Block, Regional Anesthesia

Status
Not yet recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Erector spinae plane block
Placebo Block
Sponsored by
Women's College Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Breast Cancer focused on measuring Spinae fascial plane block, Breast surgery, interfascial plane block, erector spinae block

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ASA classification: I-III
  • BMI < 35 kg/m2
  • Day surgery procedure

Exclusion Criteria:

  • Prior ipsilateral breast surgery, excluding lumpectomy
  • Pre-existing neurological deficit or peripheral neuropathy involving the ipsilateral chest
  • Severe, poorly controlled cardiac conditions, significant arrhythmias, severe valvular heart diseases
  • Severe, poorly controlled respiratory conditions (severe COPD, severe interstitial lung disease, severe / poorly controlled asthma)
  • Contraindication to regional anaesthesia (e.g. bleeding diathesis, coagulopathy, sepsis, infection at the site of potential needle puncture on the posterior chest)
  • Patient refusal
  • Chronic pain disorder
  • Chronic opioid use (≥30 mg oxycodone / day)
  • Contraindication (or allergy) to a component of multi-modal analgesia protocol
  • Allergy to amide local anaesthetics used in nerve blocks
  • Contraindications to any of the components of the standardized general anaesthesia
  • Significant psychiatric disorder that would preclude objective study assessment
  • Pregnancy/ women with nursing infants
  • Unable to provide informed consent
  • Unable to speak and read English

Sites / Locations

  • Women's College Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

Control Group

Erector spinae plane (ESP) block group

Arm Description

Patients randomised to the Control group will then receive a sham subcutaneous injection of 0.5ml normal saline injected at the same site as the ESP block (see above) under ultrasound guidance to stimulate a real block procedure.

Local anaesthetic infiltration utilising 1% lidocaine will occur, and an 80mm 22G block needle will be inserted using an in-plane cranial to caudad approach, the needle will be advanced to target the interfascial plane deep to the erector spinae muscle at the T2 transverse process. Once the needle tip is in the correct position, 20 ml of the local anaesthetic (ropivacaine 0.5% with 1:400,000 epinephrine) will be administered slowly in 5 ml aliquots under frequent aspiration and correct spread in the interfascial plane will be observed.

Outcomes

Primary Outcome Measures

Acute postoperative pain at rest
Following breast surgery, measured as an area under the curve (AUC) of rest pain scores VAS scale where 0 corresponds to no pain, and 10 corresponds to worst pain imaginable
Quality of postoperative recovery (QoR 15)
Quality of recovery at 24 hours: questionnaire (0-10, where 0 = none of the time [poor] and 10 = all of the time [excellent])

Secondary Outcome Measures

Postoperative pain scores
VAS scale where 0 corresponds to no pain, and 10 corresponds to worst pain imaginable
Intraoperative opioid consumption
Cumulative oral morphine equivalent after surgery
Postoperative opioid consumption
Cumulative oral morphine equivalent after surgery
Duration of phase I (PACU) and phase II (surgical day care, SDC) stay
How fast is the recovery is-expressed in minutes
Opioid-related side effects
Risk of opioid-related side effects(nausea, vomiting, pruritis)
Persistent post surgical pain DN4 screening tool
Satisfaction with pain management. Is prescribed pain medication enough?
Block-related complications
bruising at injection site, numbness over lateral chest, weakness of shoulder or arm, pain/swelling at injection site

Full Information

First Posted
March 25, 2019
Last Updated
April 24, 2023
Sponsor
Women's College Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03978780
Brief Title
Erector Spinae Block vs. Placebo Block Study
Official Title
Quality of Recovery Scores Following Erector Spinae Block vs. Sham Block in Ambulatory Breast Cancer Surgery: A Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 2023 (Anticipated)
Primary Completion Date
September 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Women's College Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Regional anaesthesia combined with general anaesthesia has become common in the perioperative management of breast cancer surgery patients. Regional techniques have been recognised to provide excellent post-operative analgesia. It enhances multi-modal analgesia regimes while being opioid sparing, reducing incidence of post-operative nausea and vomiting and allowing earlier mobilisation/discharge and improving treatment success. Therefore identifying the correct regional anaesthetic technique for this group of patients is important in providing optimum peri-operative care.
Detailed Description
The ultrasound-guided erector spinae plane (ESP) block has been recently described for the successful management of thoracic neuropathic pain. The erector spinae muscle is formed by the spinalis, longissimus thoracis, and iliocostalis muscles that run vertically in the back. The ESP block is performed by depositing the local anaesthetic in the fascial plane, deep to the erector spinae muscle, at the tip of the transverse process of the vertebra. Indirect access to the paravertebral space is gained providing analgesia without the risk of needle injury to structures in close proximity. Cadaveric studies have shown both ventral and dorsal rami of thoracic spinal nerves are affected when local anaesthetic is injected deep to the erector spinae muscle. The erector spinae muscle extends along the thoracolumbar spine allowing extensive cranio-caudal spread. The ventral ramus (intercostal nerve) is divided into the anterior and lateral branches. Its terminal branches provide the sensory innervation of the entire anterolateral wall. The dorsal ramus is divided into 2 terminal branches and it gives the sensory innervation to the posterior wall. Anterior spread of the local anaesthetic to the paravertebral space through the costotransverse foramina and the intertransverse complex provides both visceral and somatic analgesia. While recent evidence supports statistically significant reductions in pain and opioid consumption among patients who receive an ESP block compared to systemic analgesia alone, the clinical significance of these differences are questionable the effect of ESP block on the patients' quality of recovery following ambulatory breast cancer surgery remains unclear. Therefore, our objective is to determine whether or not the addition of an ESP block provides both superior analgesia and quality of recovery in patients undergoing ambulatory breast cancer surgery compared to systemic analgesia alone. We hypothesis that patients who received a preoperative ESP block will afford superior postoperative analgesia and improve the quality of recovery over the first 24 hours following surgery compared to those who receive a sham block for their ambulatory breast cancer surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer, Nerve Block, Regional Anesthesia, Neuromuscular Blockade
Keywords
Spinae fascial plane block, Breast surgery, interfascial plane block, erector spinae block

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This will be a prospective, double-blinded, randomised controlled trial conducted at Women's College Hospital. The study will enroll patients undergoing unilateral breast cancer surgery involving sentinel lymph node biopsy, axillary lymph node dissection and total axillary lymph node clearance. After obtaining written informed consent from eligible patients, study participants will be randomly assigned to one of two groups, the Erector spinae block group and the Control group.
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
Blinded for patient, assessor, anesthesiologist in the operating room
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control Group
Arm Type
Placebo Comparator
Arm Description
Patients randomised to the Control group will then receive a sham subcutaneous injection of 0.5ml normal saline injected at the same site as the ESP block (see above) under ultrasound guidance to stimulate a real block procedure.
Arm Title
Erector spinae plane (ESP) block group
Arm Type
Experimental
Arm Description
Local anaesthetic infiltration utilising 1% lidocaine will occur, and an 80mm 22G block needle will be inserted using an in-plane cranial to caudad approach, the needle will be advanced to target the interfascial plane deep to the erector spinae muscle at the T2 transverse process. Once the needle tip is in the correct position, 20 ml of the local anaesthetic (ropivacaine 0.5% with 1:400,000 epinephrine) will be administered slowly in 5 ml aliquots under frequent aspiration and correct spread in the interfascial plane will be observed.
Intervention Type
Procedure
Intervention Name(s)
Erector spinae plane block
Intervention Description
80mm 22G block needle will be inserted using an in-plane cranial to caudad approach, the needle will be advanced to target the interfascial plane deep to the erector spinae muscle at the T2 transverse process. Once the needle tip is in the correct position, 20 ml of the local anaesthetic (ropivacaine 0.5% with 1:400,000 epinephrine) will be administered slowly in 5 ml aliquots under frequent aspiration and correct spread in the interfascial plane will be observed.
Intervention Type
Procedure
Intervention Name(s)
Placebo Block
Intervention Description
Patients randomised to the Control group will then receive a sham subcutaneous injection of 0.5ml normal saline injected at the same site as the ESP block under ultrasound guidance to stimulate a real block procedure.
Primary Outcome Measure Information:
Title
Acute postoperative pain at rest
Description
Following breast surgery, measured as an area under the curve (AUC) of rest pain scores VAS scale where 0 corresponds to no pain, and 10 corresponds to worst pain imaginable
Time Frame
24 hours postoperatively
Title
Quality of postoperative recovery (QoR 15)
Description
Quality of recovery at 24 hours: questionnaire (0-10, where 0 = none of the time [poor] and 10 = all of the time [excellent])
Time Frame
24 hours post-surgery
Secondary Outcome Measure Information:
Title
Postoperative pain scores
Description
VAS scale where 0 corresponds to no pain, and 10 corresponds to worst pain imaginable
Time Frame
0, 6, 12, 18, 24 and 48 hours post-operatively
Title
Intraoperative opioid consumption
Description
Cumulative oral morphine equivalent after surgery
Time Frame
During the procedure
Title
Postoperative opioid consumption
Description
Cumulative oral morphine equivalent after surgery
Time Frame
12,24,48 hours, 7 days postoperative
Title
Duration of phase I (PACU) and phase II (surgical day care, SDC) stay
Description
How fast is the recovery is-expressed in minutes
Time Frame
From end of surgical procedure to 24 hours after surgery
Title
Opioid-related side effects
Description
Risk of opioid-related side effects(nausea, vomiting, pruritis)
Time Frame
End of surgical procedure to 48 hours after surgery
Title
Persistent post surgical pain DN4 screening tool
Description
Satisfaction with pain management. Is prescribed pain medication enough?
Time Frame
3 months post operatively
Title
Block-related complications
Description
bruising at injection site, numbness over lateral chest, weakness of shoulder or arm, pain/swelling at injection site
Time Frame
End of surgical procedure to 48 hours after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ASA classification: I-III BMI < 35 kg/m2 Day surgery procedure Exclusion Criteria: Prior ipsilateral breast surgery, excluding lumpectomy Pre-existing neurological deficit or peripheral neuropathy involving the ipsilateral chest Severe, poorly controlled cardiac conditions, significant arrhythmias, severe valvular heart diseases Severe, poorly controlled respiratory conditions (severe COPD, severe interstitial lung disease, severe / poorly controlled asthma) Contraindication to regional anaesthesia (e.g. bleeding diathesis, coagulopathy, sepsis, infection at the site of potential needle puncture on the posterior chest) Patient refusal Chronic pain disorder Chronic opioid use (≥30 mg oxycodone / day) Contraindication (or allergy) to a component of multi-modal analgesia protocol Allergy to amide local anaesthetics used in nerve blocks Contraindications to any of the components of the standardized general anaesthesia Significant psychiatric disorder that would preclude objective study assessment Pregnancy/ women with nursing infants Unable to provide informed consent Unable to speak and read English
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Didem Bozak
Phone
416-323-6008
Email
didem.bozak@wchospital.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Richard Brull, MD,FRCPC
Organizational Affiliation
Women's College Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Women's College Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5S 1B2
Country
Canada
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Richard Brull, MD
Phone
416-323-6400
Ext
4239
Email
richard.brull@wchospital.ca
First Name & Middle Initial & Last Name & Degree
Didem Bozak
Phone
416-323-6400
Ext
6008
Email
didem.bozak@wchospital.ca

12. IPD Sharing Statement

Citations:
PubMed Identifier
23923989
Citation
Blanco R, Parras T, McDonnell JG, Prats-Galino A. Serratus plane block: a novel ultrasound-guided thoracic wall nerve block. Anaesthesia. 2013 Nov;68(11):1107-13. doi: 10.1111/anae.12344. Epub 2013 Aug 7.
Results Reference
background
PubMed Identifier
30640653
Citation
Mazzinari G, Rovira L, Casasempere A, Ortega J, Cort L, Esparza-Minana JM, Belaouchi M. Interfascial block at the serratus muscle plane versus conventional analgesia in breast surgery: a randomized controlled trial. Reg Anesth Pain Med. 2019 Jan;44(1):52-58. doi: 10.1136/rapm-2018-000004.
Results Reference
background
PubMed Identifier
27501016
Citation
Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):621-7. doi: 10.1097/AAP.0000000000000451.
Results Reference
background
PubMed Identifier
29980005
Citation
Gurkan Y, Aksu C, Kus A, Yorukoglu UH, Kilic CT. Ultrasound guided erector spinae plane block reduces postoperative opioid consumption following breast surgery: A randomized controlled study. J Clin Anesth. 2018 Nov;50:65-68. doi: 10.1016/j.jclinane.2018.06.033. Epub 2018 Jul 2.
Results Reference
background

Learn more about this trial

Erector Spinae Block vs. Placebo Block Study

We'll reach out to this number within 24 hrs